Most cancers favor glycolytic-based glucose metabolism. Hexokinase-2 (HK2), the first glycolytic rate-limiting enzyme, shows limited expression in normal adult tissues but is overexpressed in many tumor tissue...
from Most Recent Articles: Journal of Nanobiotechnology https://ift.tt/38mQWQx
via IFTTT
No comments:
Post a Comment